Merck of Germany is building on its drug discovery collaboration with charity Cancer Research UK and The Institute of Cancer Research, London, with a multi-project deal which, if successful, would give Merck KGAA worldwide rights to take molecules discovered into clinical development.
This three-project alliance follows previous single project drug discovery collaborations and a more recent target validation collaboration between Merck and...








